Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

European Heart Rhythm Ass… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Artikel i vetenskaplig tidskrift
Författare Carina Blomström-Lundqvist
Vassil Traykov
Paola Anna Erba
Haran Burri
Jens Cosedis Nielsen
Maria Grazia Bongiorni
Jeanne Poole
Giuseppe Boriani
Roberto Costa
Jean-Claude Deharo
Laurence M Epstein
Laszlo Saghy
Ulrika Snygg-Martin
Christoph Starck
Carlo Tascini
Neil Strathmore
Publicerad i European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Volym 57
Nummer/häfte 1
Sidor 1–31
ISSN 1873-734X
Publiceringsår 2020
Publicerad vid Institutionen för biomedicin, avdelningen för infektionssjukdomar
Sidor 1–31
Språk en
Länkar dx.doi.org/10.1093/ejcts/ezz296
www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Cardiac implantable electronic devices, CIED, Endocarditis, Infection
Ämneskategorier Infektionsmedicin

Sammanfattning

Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices are potentially life-saving treatments for a number of cardiac conditions, but are not without risk. Most concerning is the risk of a cardiac implantable electronic device (CIED) infection, which is associated with significant morbidity, increased hospitalizations, reduced survival, and increased healthcare costs. Recommended preventive strategies such as administration of intravenous antibiotics before implantation are well recognized. Uncertainties have remained about the role of various preventive, diagnostic, and treatment measures such as skin antiseptics, pocket antibiotic solutions, anti-bacterial envelopes, prolonged antibiotics post-implantation, and others. Guidance on whether to use novel device alternatives expected to be less prone to infections and novel oral anticoagulants is also limited, as are definitions on minimum quality requirements for centres and operators and volumes. Moreover, an international consensus document on management of CIED infections is lacking. The recognition of these issues, the dissemination of results from important randomized trials focusing on prevention of CIED infections, and observed divergences in managing device-related infections as found in an European Heart Rhythm Association worldwide survey, provided a strong incentive for a 2019 International State-of-the-art Consensus document on risk assessment, prevention, diagnosis, and treatment of CIED infections.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?

Denna text är utskriven från följande webbsida:
http://gu.se/forskning/publikation/?languageId=100000&disableRedirect=true&returnUrl=http%3A%2F%2Fgu.se%2Fenglish%2Fresearch%2Fpublication%2F%3Fprint%3Dtrue%26publicationId%3D286259&publicationId=286259
Utskriftsdatum: 2020-04-10